GB2465088A8 - Methods for assessing RNA patterns - Google Patents

Methods for assessing RNA patterns Download PDF

Info

Publication number
GB2465088A8
GB2465088A8 GB0920030A GB0920030A GB2465088A8 GB 2465088 A8 GB2465088 A8 GB 2465088A8 GB 0920030 A GB0920030 A GB 0920030A GB 0920030 A GB0920030 A GB 0920030A GB 2465088 A8 GB2465088 A8 GB 2465088A8
Authority
GB
United Kingdom
Prior art keywords
methods
assessing rna
rna patterns
patterns
assessing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB0920030A
Other versions
GB2465088B (en
GB2465088C (en
GB0920030D0 (en
GB2465088A9 (en
GB2465088A (en
Inventor
Michael Klass
Christine Kuslich
George Poste
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Caris Life Sciences Inc
Original Assignee
Caris MPI Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Caris MPI Inc filed Critical Caris MPI Inc
Priority claimed from PCT/US2009/062880 external-priority patent/WO2010062706A2/en
Publication of GB0920030D0 publication Critical patent/GB0920030D0/en
Publication of GB2465088A publication Critical patent/GB2465088A/en
Publication of GB2465088A9 publication Critical patent/GB2465088A9/en
Publication of GB2465088A8 publication Critical patent/GB2465088A8/en
Publication of GB2465088B publication Critical patent/GB2465088B/en
Application granted granted Critical
Publication of GB2465088C publication Critical patent/GB2465088C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB0920030.4A 2008-10-30 2009-10-30 miRNA expression in the characterisation and classification of cancer Expired - Fee Related GB2465088C (en)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US10974208P 2008-10-30 2008-10-30
US11257108P 2008-11-07 2008-11-07
US11405808P 2008-11-12 2008-11-12
US11404508P 2008-11-12 2008-11-12
US11406508P 2008-11-13 2008-11-13
US15118309P 2009-02-09 2009-02-09
US27804909P 2009-10-02 2009-10-02
US25045409P 2009-10-09 2009-10-09
US25302709P 2009-10-19 2009-10-19
PCT/US2009/062880 WO2010062706A2 (en) 2008-10-30 2009-10-30 Methods for assessing rna patterns

Publications (6)

Publication Number Publication Date
GB0920030D0 GB0920030D0 (en) 2009-12-30
GB2465088A GB2465088A (en) 2010-05-12
GB2465088A9 GB2465088A9 (en) 2010-06-30
GB2465088A8 true GB2465088A8 (en) 2010-12-01
GB2465088B GB2465088B (en) 2012-07-18
GB2465088C GB2465088C (en) 2016-01-27

Family

ID=41509440

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0920030.4A Expired - Fee Related GB2465088C (en) 2008-10-30 2009-10-30 miRNA expression in the characterisation and classification of cancer

Country Status (1)

Country Link
GB (1) GB2465088C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103861121A (en) * 2012-12-10 2014-06-18 中国医学科学院基础医学研究所 Use of micro-RNA molecule miR491-5p in treatment and/or diagnosis and/or prognosis of pancreatic cancer

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2791905A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Biomarkers for theranostics
JP2013526852A (en) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス Circulating biomarkers for disease
US20150329911A1 (en) * 2012-10-10 2015-11-19 Institute Of Cancer Research: Royal Cancer Hospital Nucleic acid biomarkers for prostate cancer
EP2961327B1 (en) 2013-02-27 2018-07-11 Koninklijke Philips N.V. Optical guided vacuum assisted biopsy device

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6737506B1 (en) * 1998-02-25 2004-05-18 Paul Anziano Manganese superoxide dismutase exon 3-deleted isoforms and nucleic acid molecules encoding the isoforms
AU2003291433B2 (en) * 2002-11-13 2008-05-22 Thomas Jefferson University Compositions and methods for cancer diagnosis and therapy
WO2004070056A2 (en) * 2003-02-07 2004-08-19 Diagnocure Inc. Method to detect prostate cancer in a sample
CA2491067A1 (en) * 2004-12-24 2006-06-24 Stichting Katholieke Universiteit Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer
ES2461189T3 (en) * 2006-01-05 2014-05-19 The Ohio State University Research Foundation MicroRNA-based methods and compositions for the diagnosis and treatment of solid breast or lung cancers
WO2008112283A2 (en) * 2007-03-12 2008-09-18 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment
US8895525B2 (en) * 2007-10-29 2014-11-25 University Of Southern California Preventing hyaluronan-mediated tumorigenetic mechanisms using intronic RNAs
EP3112477A1 (en) * 2008-02-28 2017-01-04 The Ohio State University Research Foundation Microrna-based methods and compositions for the diagnosis, prognosis and treatment of prostate related disorders

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103861121A (en) * 2012-12-10 2014-06-18 中国医学科学院基础医学研究所 Use of micro-RNA molecule miR491-5p in treatment and/or diagnosis and/or prognosis of pancreatic cancer
CN103861121B (en) * 2012-12-10 2016-02-24 中国医学科学院基础医学研究所 The purposes of microRNA molecules miR491-5p in the treatment of cancer of pancreas and/or diagnosis and/or prognosis

Also Published As

Publication number Publication date
GB2465088B (en) 2012-07-18
GB2465088C (en) 2016-01-27
GB0920030D0 (en) 2009-12-30
GB2465088A9 (en) 2010-06-30
GB2465088A (en) 2010-05-12

Similar Documents

Publication Publication Date Title
IL233188A0 (en) Methods for assessing rna patterns
GB0820927D0 (en) Method
GB0803107D0 (en) Method
GB0818093D0 (en) Method
GB0822836D0 (en) Method
GB0810418D0 (en) Method
EP2336393A4 (en) Electroforming method
GB0807409D0 (en) Method
GB0815428D0 (en) Method
GB0813599D0 (en) Method
GB0807410D0 (en) Method
GB0804981D0 (en) Method
GB0804690D0 (en) Method
GB0809404D0 (en) Method
EP2321435A4 (en) Recarburisation method
GB2465088A8 (en) Methods for assessing RNA patterns
GB0812559D0 (en) Method
GB0805862D0 (en) Method
GB0813494D0 (en) Method
LU91569B1 (en) Prognostic method
GB0812102D0 (en) Method
GB0806186D0 (en) Method
GB0811166D0 (en) Method
GB0810116D0 (en) Method
GB0816867D0 (en) Method

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20130215 AND 20130220

S117 Correction of errors in patents and applications (sect. 117/patents act 1977)

Free format text: REQUEST FILED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 14 AUGUST 2014

S117 Correction of errors in patents and applications (sect. 117/patents act 1977)

Free format text: CORRECTIONS ALLOWED; REQUEST FOR CORRECTION UNDER SECTION 117 FILED ON 14 AUGUST 2014, ALLOWED ON 20 JANUARY 2016

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20161030